Onesource Specialty Pharma Limited has informed the Exchange regarding 'Delisting of NCD's from BSE'.
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The company has informed the exchanges that its 20,000 secured, rated, listed, redeemable Non-Convertible Debentures (NCDs) on BSE have been delisted. These NCDs (ISIN: INE013P07028, Scrip Code: 975645) were originally listed on May 8, 2024. The company fully redeemed the NCDs on November 28, 2024, and submitted a delisting application on June 5, 2025. BSE approved the delisting, and the company was notified on June 21, 2025. This is a routine administrative step after the debt was already fully repaid to investors.
No impact on equity shareholders or the stock price — this is simply a cleanup of already-redeemed debt instruments and does not affect the company's listed equity shares on NSE or BSE.